drug development

  1. H

    India’s Bioeconomy Surpasses $200 Billion, Signaling Growth

    New Delhi, March 31: India's bioeconomy is approaching the $200 billion mark, which is a significant milestone in its development, according to a report released on Tuesday. This is due to strong policy support and a growing pipeline of innovation.The report by Endiya Partners said that the...
  2. H

    Lupin's Generic Drug for Daytime Sleepiness Receives USFDA Review

    Lupin Receives Tentative USFDA Approval for Generic Pitolisant Tablets New Delhi, March 25 – Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime...
  3. K

    Weight Loss Drug Collaboration: Novo Nordisk and Hims

    Novo Nordisk Drops Lawsuit Against Hims & Hers After Agreement to Sell Wegovy and Ozempic Through Platform Novo Nordisk has dropped its lawsuit against telehealth company Hims & Hers after both firms reached an agreement that will allow the pharmaceutical company’s branded weight loss...
  4. K

    Government Boosts India's Chemical Industry for $1 Trillion Turnover

    India Targets 5 to 6 Percent Global Chemical Share by 2030, Eyes $1 Trillion Turnover by 2040 Government Bets on Bio-Pharma SHAKTI and Chemical Parks to Boost Sector Growth New Delhi, March 4: India is positioning itself for a major leap in the global chemical and biopharmaceutical landscape...
Back
Top